---
figid: PMC5189614__theoncologist_15519_f1
figtitle: Cellular control of hyperglycemia
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5189614
filename: theoncologist_15519_f1.jpg
figlink: /pmc/articles/PMC5189614/figure/F1/
number: F1
caption: 'Cellular control of hyperglycemia. Glucose homeostasis is maintained at
  a cellular level through activation of the intracellular PI3K/AKT/mTOR pathway downstream
  of IGF-1R and IR. These receptors, along with EGFR, can also activate the Ras/MAPK/ERK
  pathway, which plays a role in cellular proliferation and survival. Targeted therapies
  designed to inhibit cancer cell proliferation and promote apoptosis act on these
  pathways at multiple points (red circles).Abbreviations: EGF, epidermal growth factor;
  EGFR, epidermal growth factor receptor; IGF, insulin growth factor; IGF-1R, insulin
  growth factor receptor 1; IR, insulin receptor.'
papertitle: 'Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms
  and Management.'
reftext: Jonathan W. Goldman, et al. Oncologist. 2016 Nov;21(11):1326-1336.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8653776
figid_alias: PMC5189614__F1
figtype: Figure
redirect_from: /figures/PMC5189614__F1
ndex: 99a1658f-df15-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5189614__theoncologist_15519_f1.html
  '@type': Dataset
  description: 'Cellular control of hyperglycemia. Glucose homeostasis is maintained
    at a cellular level through activation of the intracellular PI3K/AKT/mTOR pathway
    downstream of IGF-1R and IR. These receptors, along with EGFR, can also activate
    the Ras/MAPK/ERK pathway, which plays a role in cellular proliferation and survival.
    Targeted therapies designed to inhibit cancer cell proliferation and promote apoptosis
    act on these pathways at multiple points (red circles).Abbreviations: EGF, epidermal
    growth factor; EGFR, epidermal growth factor receptor; IGF, insulin growth factor;
    IGF-1R, insulin growth factor receptor 1; IR, insulin receptor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - IGF1
  - IGF1R
  - EGFR
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - GRB2
  - XYLT2
  - SOS1
  - SOS2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - Egfr
  - IRSp53
  - IleRS
  - chico
  - Shc
  - drk
  - Sos
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Akt
  - Dsor1
  - Mtk
  - Mtor
  - Tor
  - Erk7
  - rl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - rociletinib
  - afuresertib
  - temsirolimus
  - ridaforolimus
  - BEZ235
  - PF-05212384
  - PKI-587
  - linsitinib
  - GDC-0980
  - PF-04691502
  - ceritinib
  - Glucose
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
